Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H12Cl2F3N7O2S |
| Molecular Weight | 506.289 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC(=O)C1=NC=NC(N)=C1Cl)C2=NC=C(S2)C(=O)NC3=CC(=C(Cl)C=N3)C(F)(F)F
InChI
InChIKey=VWMJHAFYPMOMGF-ZCFIWIBFSA-N
InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1
| Molecular Formula | C17H12Cl2F3N7O2S |
| Molecular Weight | 506.289 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:25:09 UTC 2023
by
admin
on
Sat Dec 16 01:25:09 UTC 2023
|
| Record UNII |
ZN90E4027M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
410813
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
||
|
FDA ORPHAN DRUG |
768320
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3348923
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
25161177
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
DTXSID70149011
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
JK-261
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
1096708-71-2
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
ZN90E4027M
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
167672
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
11985
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
C106254
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
100000183294
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY | |||
|
DB15266
Created by
admin on Sat Dec 16 01:25:09 UTC 2023 , Edited by admin on Sat Dec 16 01:25:09 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET->WEAK INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
